Form 8-K - Current report:
SEC Accession No. 0001753926-24-001333
Filing Date
2024-08-01
Accepted
2024-08-01 17:20:21
Documents
23
Period of Report
2024-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084368_8k.htm   iXBRL 8-K 51757
2 EXHIBIT 4.1 g084368_ex4-1.htm EX-4.1 108537
3 EXHIBIT 4.2 g084368_ex4-2.htm EX-4.2 118842
4 EXHIBIT 5.1 g084368_ex5-1.htm EX-5.1 12784
5 EXHIBIT 10.1 g084368_ex10-1.htm EX-10.1 238420
6 EXHIBIT 10.2 g084368_ex10-2.htm EX-10.2 56580
7 EXHIBIT 99.1 g084368_ex99-1.htm EX-99.1 11158
8 EXHIBIT 99.2 g084368_ex99-2.htm EX-99.2 9609
9 GRAPHIC ex0501_image.jpg GRAPHIC 5908
10 GRAPHIC ex0501_image2.jpg GRAPHIC 1753
11 GRAPHIC img001.jpg GRAPHIC 10859
  Complete submission text file 0001753926-24-001333.txt   947860

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE lipo-20240801.xsd EX-101.SCH 3012
13 XBRL LABEL FILE lipo-20240801_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE lipo-20240801_pre.xml EX-101.PRE 22357
25 EXTRACTED XBRL INSTANCE DOCUMENT g084368_8k_htm.xml XML 3857
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 241167940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)